690 related articles for article (PubMed ID: 23994266)
1. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
[TBL] [Abstract][Full Text] [Related]
2. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
3. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
Feary M; Racher AJ; Young RJ; Smales CM
Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785
[TBL] [Abstract][Full Text] [Related]
4. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
[TBL] [Abstract][Full Text] [Related]
5. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.
Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z
MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114
[TBL] [Abstract][Full Text] [Related]
6. A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression.
Daramola O; Stevenson J; Dean G; Hatton D; Pettman G; Holmes W; Field R
Biotechnol Prog; 2014; 30(1):132-41. PubMed ID: 24106171
[TBL] [Abstract][Full Text] [Related]
7. Limitations to the development of humanized antibody producing Chinese hamster ovary cells using glutamine synthetase-mediated gene amplification.
Jun SC; Kim MS; Hong HJ; Lee GM
Biotechnol Prog; 2006; 22(3):770-80. PubMed ID: 16739961
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of instability of Chinese hamster ovary cell lines expressing recombinant antibodies and antibody-fusion proteins.
Dorai H; Corisdeo S; Ellis D; Kinney C; Chomo M; Hawley-Nelson P; Moore G; Betenbaugh MJ; Ganguly S
Biotechnol Bioeng; 2012 Apr; 109(4):1016-30. PubMed ID: 22068683
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of glutamine synthetase selection marker improves product titer and reduces glutamine overflow in Chinese hamster ovary cells.
Sacco SA; Tuckowski AM; Trenary I; Kraft L; Betenbaugh MJ; Young JD; Smith KD
Biotechnol Bioeng; 2022 Jul; 119(7):1712-1727. PubMed ID: 35312045
[TBL] [Abstract][Full Text] [Related]
10. Study of the mechanism for increased protein expression via transcription potency reduction of the selection marker.
Yang B; Zhou J; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
Bioprocess Biosyst Eng; 2019 May; 42(5):799-806. PubMed ID: 30730009
[TBL] [Abstract][Full Text] [Related]
11. Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: Methionine sulfoximine resistance.
Yu DY; Noh SM; Lee GM
J Biotechnol; 2016 Aug; 231():136-140. PubMed ID: 27288593
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies.
Noh SM; Shin S; Lee GM
Sci Rep; 2018 Mar; 8(1):5361. PubMed ID: 29599455
[TBL] [Abstract][Full Text] [Related]
13. An attempt to add biological functions by genetic engineering in order to produce high-performance bioreactor cells for hybrid artificial liver: transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell.
Enosawa S; Suzuki S; Fujino M; Amemiya H; Omasa T; Urayama S; Tanimura N; Suga K
Cell Transplant; 1997; 6(5):537-40. PubMed ID: 9331509
[TBL] [Abstract][Full Text] [Related]
14. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the efficiency and quality in developing a new CHO host cell line.
Huhn SC; Ou Y; Tang X; Jiang B; Liu R; Lin H; Du Z
Biotechnol Prog; 2021 Sep; 37(5):e3185. PubMed ID: 34142466
[TBL] [Abstract][Full Text] [Related]
16. Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker.
Pu H; Cashion LM; Kretschmer PJ; Liu Z
Mol Biotechnol; 1998 Aug; 10(1):17-25. PubMed ID: 9779420
[TBL] [Abstract][Full Text] [Related]
17. Weak promoters to drive selection marker expression: Improvement of cell line development process for therapeutic protein production in CHO-K1 cells.
Grindes L; Florimond C; Ribault S; Raymond C; Dieryck W; Joucla G; Corbin C
J Biotechnol; 2023 Jun; 369():43-54. PubMed ID: 37149043
[TBL] [Abstract][Full Text] [Related]
18. Optimization of cell line development in the GS-CHO expression system using a high-throughput, single cell-based clone selection system.
Nakamura T; Omasa T
J Biosci Bioeng; 2015 Sep; 120(3):323-9. PubMed ID: 25792187
[TBL] [Abstract][Full Text] [Related]
19. Development of transfection and high-producer screening protocols for the CHOK1SV cell system.
de la Cruz Edmonds MC; Tellers M; Chan C; Salmon P; Robinson DK; Markusen J
Mol Biotechnol; 2006 Oct; 34(2):179-90. PubMed ID: 17172663
[TBL] [Abstract][Full Text] [Related]
20. [Construction of an anti-apoptosis CHO cell line for biopharmaceutical production].
Lai DZ; Fu L; Yu CM; Qi LQ; Weng SJ; Yu T; Wang HT; Chen W
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):322-6. PubMed ID: 15969015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
